Editor's letter

“In no way do we see GLP-1 as the end of snacking,” Bosco Fonts, the CEO of Cerealto, says. “On the contrary, snacking is the unlikely winner of GLP-1.”

Cerealto, the Spain-based manufacturer of products like biscuits, cereal bars and rice cakes, is, like food manufacturers of all shapes and sizes, watching the rise of weight-less medication closely.

And it’s particularly likely executives in the more indulgent parts of the sector will be poring over the early sales data to see how the drugs are affecting demand.

In this edition’s cover story, we hear how some, like Fonts, remain confident they can ride out the wave, even if there are signs shopping habits in North America and Europe are changing.

Elsewhere in this issue, we dig into some of the questions facing Big Food as major manufacturers talk up their efforts on regenerative agriculture, head to Japan to take the temperature of the country’s alt-milk market and hear from Groupe Bel about its plans to grow in the US.

Dean Best, editor